Pain Management Test

$399.00

SKU: GEN-1770

This Pain Management test offers insight into the main pain management biomarkers to help maximize the effectiveness of analgesic drug use.

 

Collection Method: Swab

Add to WishlistAdd to Compare
Category:

 

Managing chronic pain is a challenge for healthcare providers because of each patient’s unique tolerance to pain and differing reactions to prescribed medications. Unpleasant opioid side effects, such as nausea, vomiting, constipation and sedation, are common with pain management medication.  An individual’s genetic makeup may predispose them to adverse effects of pain and reduced efficacy of medications. Pharmacogenomics may help connect the dots towards mitigating adverse drug reactions among genetically-vulnerable individuals and provide information for improved dosage recommendations for therapeutic effect.

 

Markers Include:

  • CYP2D6 – Key role in the metabolism of opioids including: codeine, tramadol, and oxycodone
  • CYP2C19 – Impacts dosages requirements for tricyclic antidepressants
  • CYP2C9 – Crucial to the breakdown of NSAIDS including: diclofenac, naproxen, and ibuprofen
  • COMT – Effects morphine dosage requirements and perceptions of pain

Related Symptoms or Conditions

  • Patients with decreased adverse drug reactions
  • New patients with mood related symptoms to provide reduced trial and error period for an effective medication

What is Included

  • Detailed step by step instructions to guide you
  • Customized barcode for easy registration
  • All materials for easy sample collection at home
  • Digital and Printable Results
  • Physician reviewed test reports
  • Help with understanding your results

There are no reviews yet.

Be the first to review “Pain Management Test”

Your email address will not be published. Required fields are marked *